Clinical Trials Logo

Drug-coated Balloon clinical trials

View clinical trials related to Drug-coated Balloon.

Filter by:

NCT ID: NCT06265324 Not yet recruiting - Drug-coated Balloon Clinical Trials

Drug-coated Balloon Treatment in Coronary Lesions

Start date: February 10, 2024
Phase: N/A
Study type: Interventional

This study is multicenter registry for drug-coated balloon treatment for de novo and in-stent restenosis lesions

NCT ID: NCT06084000 Recruiting - Drug-coated Balloon Clinical Trials

STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial

STENTLESS
Start date: October 15, 2023
Phase: N/A
Study type: Interventional

This is a multicenter, open-label, randomized controlled study meant to compare the safety and efficacy of scheduled drug-coated balloon (DCB) and conventional drug-eluting stent (DES) strategy in the treatment of de novo lesions of large coronary vessel with diameter larger than 2.75 mm. The trial was designed to provide high-quality evidence for expanding the clinical indications of DCB, and to explore a better way for coronary intervention based on DCB.

NCT ID: NCT05562089 Recruiting - Clinical trials for Myocardial Infarction

Prevail Drug Balloon Study

Start date: April 29, 2022
Phase: N/A
Study type: Interventional

This is an investigator-initiated, prospective, single-centre, non-randomized, all-comers registry that evaluates the safety and efficacy of any Paclitaxel Drug-Coated Balloon (DCB) for the treatment of coronary de novo lesion, in-stent restenosis, and small vessel disease in patients with coronary artery disease in Hong Kong. The recruitment time frame of this study is 1 year from 1st January 2022 to 30th December 2022.

NCT ID: NCT05101005 Not yet recruiting - Clinical trials for Coronary Artery Disease

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Start date: October 2021
Phase: N/A
Study type: Interventional

To evaluate the efficacy of drug-coated balloon versus drug-eluting stent for the treatment of large de novo coronary lesions(RVD=2.75~4.0mm).

NCT ID: NCT04984135 Completed - Coronary Stenosis Clinical Trials

DCB Angioplasty for Coronary Lesions: an OCT Analysis

Start date: December 1, 2020
Phase:
Study type: Observational [Patient Registry]

In this study, the investigators preformed OCT before and after DCB treatment, as well as at 6 months of follow-up, to assess the tissue characterization. The aim of this study was to investigate the relationship between quantitative and qualitative OCT findings, angiographic and clinical outcomes after PCB for coronary lesions.

NCT ID: NCT04937803 Active, not recruiting - Clinical trials for Coronary Artery Disease

Safety and Efficacy of Drug-Coated Balloon for De-novo Lesions in Patients With Acute Coronary Syndromes (DCB-ACS)

DCB-ACS
Start date: April 19, 2021
Phase: N/A
Study type: Interventional

The DCB-ACS trial is a prospective, multi-center, non-inferiority, randomized controlled trail. The purpose of this trial is to evaluate the safety and efficacy of drug-coated balloon(DCB) in de novo lesions for acute coronary syndromes (ACS) .

NCT ID: NCT04826705 Active, not recruiting - Angioplasty Clinical Trials

A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon

PROMISING
Start date: February 1, 2021
Phase:
Study type: Observational [Patient Registry]

There have been a number of randomized controlled studies (RCT) showing the efficacy of the endovascular treatment with drug-coated balloons (DCB) in the femoropopliteal artery lesions. However, these studies have been carefully designed, and most of them have excluded long-length lesions and severely calcified lesions. In addition to being used alone in the real word, drug-coated balloons (DCB) are also used in combination with stents or debulking devices, but in these randomized controlled studies (RCT) they are only compared with standard percutaneous transluminal angioplasty (PTA). Therefore, the investigators initiated this study, which is a prospective, multicenter, observational real-world study of short and long-term outcome in endovascular treatment of femoropopliteal arterial occlusive lesions with DCB.

NCT ID: NCT04778969 Not yet recruiting - Clinical trials for Coronary Artery Disease

Kor PCI - CAD Patients Treated With PCI: Analysis of the Korean Nationwide Health Insurance Database

Start date: April 1, 2021
Phase:
Study type: Observational

Current Status and Prognosis of Coronary artery disease patients treated with coronary intervention - Analysis of the Korean Nationwide Health Insurance Database

NCT ID: NCT04737291 Not yet recruiting - Drug Coated Balloon Clinical Trials

Drug Coated Ballon in Critical Limb Ischemia

DCB
Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Evaluate the safety and efficacy of drug coated balloon (DCB) for the treatment of femoropopliteal lesions in patients with critical limb ischemia (CLI)

NCT ID: NCT04619277 Recruiting - Drug-coated Balloon Clinical Trials

Impact of Drug-coated Balloon Treatment in de Novo Coronary Lesion

Start date: April 22, 2011
Phase:
Study type: Observational [Patient Registry]

This study is the international multicenter registry for drug-coated balloon treatment for de novo coronary lesion.